Researcher receives $2.7 million grant to study lingering Lyme disease symptoms

FHS
July 14, 2023
6:48 pm

An estimated 1,200 Americans, on average, are diagnosed with Lyme disease each day. Some of those patients continue to experience negative effects, even after treatment.

Assessing Patient Fitness for Transplant in Multiple Myeloma

While high-dose chemotherapy and autologous hematopoietic cell transplantation (HCT) can deepen remissions and improve outcomes for multiple myeloma, these treatments come with significant risks, particularly

November 19, 2024

Complete Genomics Garners the Prestigious 2023 R&D 100 Awards for Cutting-Edge Innovation

SAN JOSE, CALIFORNIA, 23 August, 2023- Complete Genomics, Inc., a pioneering genomic sequencing company, today proudly received the honor of the R&D 100 Awards from R&D

August 24, 2023

WuXi AppTec slashes 2023 growth revenue forecast in half due to drop in demand for early-stage services

Biopharma manufacturer WuXi AppTec is cutting its projected 2023 growth revenue from 5-7% to 2-3% after reduced business for its early-stage drug discovery services. Specifically,

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.